annual EBIT:
-$338.85M-$116.25M(-52.22%)Summary
- As of today (July 1, 2025), CRNX annual earnings before interest & taxes is -$338.85 million, with the most recent change of -$116.25 million (-52.22%) on December 31, 2024.
- During the last 3 years, CRNX annual EBIT has fallen by -$231.15 million (-214.62%).
- CRNX annual EBIT is now -5540.05% below its all-time high of -$6.01 million, reached on December 31, 2016.
Performance
CRNX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$111.41M-$16.66M(-17.58%)Summary
- As of today (July 1, 2025), CRNX quarterly earnings before interest & taxes is -$111.41 million, with the most recent change of -$16.66 million (-17.58%) on March 31, 2025.
- Over the past year, CRNX quarterly EBIT has dropped by -$37.88 million (-51.51%).
- CRNX quarterly EBIT is now -6672.34% below its all-time high of -$1.65 million, reached on June 30, 2017.
Performance
CRNX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$376.73M-$37.88M(-11.18%)Summary
- As of today (July 1, 2025), CRNX TTM earnings before interest & taxes is -$376.73 million, with the most recent change of -$37.88 million (-11.18%) on March 31, 2025.
- Over the past year, CRNX TTM EBIT has dropped by -$128.57 million (-51.81%).
- CRNX TTM EBIT is now -14367.36% below its all-time high of -$2.60 million, reached on March 31, 2017.
Performance
CRNX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CRNX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -52.2% | -51.5% | -51.8% |
| 3 y3 years | -214.6% | -229.3% | -217.6% |
| 5 y5 years | -529.5% | -526.5% | -478.2% |
CRNX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -214.6% | at low | -158.8% | at low | -177.9% | at low |
| 5 y | 5-year | -529.5% | at low | -558.1% | at low | -478.2% | at low |
| alltime | all time | -5540.1% | at low | -6672.3% | at low | <-9999.0% | at low |
CRNX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$111.41M(+17.6%) | -$376.73M(+11.2%) |
| Dec 2024 | -$338.85M(+52.2%) | -$94.75M(+7.9%) | -$338.85M(+10.5%) |
| Sep 2024 | - | -$87.80M(+6.1%) | -$306.77M(+10.4%) |
| Jun 2024 | - | -$82.78M(+12.6%) | -$277.95M(+12.0%) |
| Mar 2024 | - | -$73.53M(+17.3%) | -$248.16M(+11.5%) |
| Dec 2023 | -$222.61M(+32.6%) | -$62.66M(+6.2%) | -$222.61M(+7.3%) |
| Sep 2023 | - | -$58.98M(+11.3%) | -$207.51M(+8.1%) |
| Jun 2023 | - | -$52.99M(+10.5%) | -$191.98M(+5.5%) |
| Mar 2023 | - | -$47.98M(+0.9%) | -$182.03M(+8.4%) |
| Dec 2022 | -$167.88M(+55.9%) | -$47.56M(+9.4%) | -$167.88M(+11.0%) |
| Sep 2022 | - | -$43.45M(+1.0%) | -$151.21M(+11.5%) |
| Jun 2022 | - | -$43.05M(+27.3%) | -$135.57M(+14.3%) |
| Mar 2022 | - | -$33.83M(+9.5%) | -$118.61M(+10.1%) |
| Dec 2021 | -$107.70M(+43.7%) | -$30.89M(+11.1%) | -$107.70M(+9.2%) |
| Sep 2021 | - | -$27.81M(+6.6%) | -$98.61M(+10.5%) |
| Jun 2021 | - | -$26.09M(+13.8%) | -$89.25M(+11.4%) |
| Mar 2021 | - | -$22.92M(+5.2%) | -$80.09M(+6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$74.95M(+39.2%) | -$21.79M(+18.1%) | -$74.95M(+9.6%) |
| Sep 2020 | - | -$18.45M(+9.0%) | -$68.38M(+4.9%) |
| Jun 2020 | - | -$16.93M(-4.8%) | -$65.15M(+5.8%) |
| Mar 2020 | - | -$17.78M(+16.9%) | -$61.57M(+14.4%) |
| Dec 2019 | -$53.83M(+87.5%) | -$15.21M(-0.1%) | -$53.83M(+12.0%) |
| Sep 2019 | - | -$15.23M(+14.1%) | -$48.05M(+17.5%) |
| Jun 2019 | - | -$13.35M(+32.9%) | -$40.89M(+23.1%) |
| Mar 2019 | - | -$10.04M(+6.5%) | -$33.23M(+15.7%) |
| Dec 2018 | -$28.71M(+214.6%) | -$9.43M(+16.9%) | -$28.71M(+31.8%) |
| Sep 2018 | - | -$8.07M(+42.0%) | -$21.78M(+35.4%) |
| Jun 2018 | - | -$5.68M(+2.8%) | -$16.09M(+33.5%) |
| Mar 2018 | - | -$5.53M(+121.2%) | -$12.05M(+32.0%) |
| Dec 2017 | -$9.13M(+51.9%) | -$2.50M(+5.0%) | -$9.13M(+37.7%) |
| Sep 2017 | - | -$2.38M(+44.7%) | -$6.63M(+56.0%) |
| Jun 2017 | - | -$1.65M(-36.8%) | -$4.25M(+63.2%) |
| Mar 2017 | - | -$2.60M | -$2.60M |
| Dec 2016 | -$6.01M | - | - |
FAQ
- What is Crinetics Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals annual EBIT year-on-year change?
- What is Crinetics Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly EBIT year-on-year change?
- What is Crinetics Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals TTM EBIT year-on-year change?
What is Crinetics Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of CRNX is -$338.85M
What is the all time high annual EBIT for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual earnings before interest & taxes is -$6.01M
What is Crinetics Pharmaceuticals annual EBIT year-on-year change?
Over the past year, CRNX annual earnings before interest & taxes has changed by -$116.25M (-52.22%)
What is Crinetics Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of CRNX is -$111.41M
What is the all time high quarterly EBIT for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$1.65M
What is Crinetics Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, CRNX quarterly earnings before interest & taxes has changed by -$37.88M (-51.51%)
What is Crinetics Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of CRNX is -$376.73M
What is the all time high TTM EBIT for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high TTM earnings before interest & taxes is -$2.60M
What is Crinetics Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, CRNX TTM earnings before interest & taxes has changed by -$128.57M (-51.81%)